GCC Organ Preservation Market Size
| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 6.87 Million |
| Market Size (2030) | USD 8.99 Million |
| CAGR (2025 - 2030) | 5.51% |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
GCC Organ Preservation Market Analysis
The GCC Organ Preservation Market size is estimated at USD 6.87 million in 2025, and is expected to reach USD 8.99 million by 2030, at a CAGR of 5.51% during the forecast period (2025-2030).
The increasing focus on organ transplantation and preservation in GCC countries is primarily driven by government initiatives, regulatory advancements, and progress in medical technology. These factors are propelling the organ preservation market in the GCC toward significant growth.
The growing need for organ transplantation is driving advancements in organ preservation techniques. In the GCC, multiple regulatory bodies oversee the critical process of organ preservation, which is vital for successful organ donation and transplantation. Organs are preserved before transplantation to maintain their quality and extend their viability. For example, the UAE's Federal Decree by Law No. (25) of 2023 appoints The National Centre as the chief authority for regulating donation procedures, as well as the preservation, distribution, and transplantation of organs, their parts, and human tissues. These regulations empower authorities to reject organs that haven't been adequately preserved. As a result, the surging demand for transplants is pushing companies to implement stringent preservation systems.
Additionally, organ transplantation is becoming increasingly significant in the GCC healthcare landscape. Regional governments are crafting policies to promote organ donation and improve transplantation services. For instance, in June 2024, Kuwait's Health Minister praised the expansion of the Simulation and Clinical Skills Centre at Arabian Gulf University, which now features the Anatomy Museum of the College of Medicine and Medical Sciences.
In addition to above context, this museum, with its collection of 122 human bodies, limbs, and organs preserved in formalin, along with educational models and real human sections in plastic, is set to enhance medical education and research in organ preservation. This development is expected to strengthen the market not just in Kuwait, but across the entire GCC.
Furthermore, in March 2024, Gulf Times reported that the Qatar Organ Donation Centre (HIBA) observed a notable increase in organ donors and transplants in 2023. That year, Hamad Medical Corporation (HMC) successfully performed 82 kidney, 11 liver, and three lung transplants. Highlighting Qatar's commitment to organ preservation, the nation's organ donor registry boasts over 530,000 registered donors, nearly a quarter of the adult population.
As GCC nations sharpen their focus on organ donation and transplantation, the demand for organ preservation technologies is set to escalate. In June 2024, Dubai rolled out new regulatory health standards for organ transplant services, a move mandated by the Dubai Health Authority (DHA). These standards apply to all transplant services, whether from living or deceased donors, underscoring DHA's dedication to enhancing healthcare with a focus on quality and patient safety. The adoption of these standards is expected to boost the effectiveness and safety of organ transplants, driving up the demand for advanced preservation solutions in Dubai and beyond.
With Kuwait investing in medical education, Qatar witnessing rising organ donation rates, and Dubai enforcing stringent health standards, the GCC's organ preservation market is on a robust growth trajectory. Yet, the steep costs associated with organ transplants in the region have curtailed both the volume of procedures and the corresponding need for preservation, posing a challenge to this growth.
GCC Organ Preservation Market Trends
The Kidney Organ Segment is Expected to Hold a Significant Market Share Over the Forecast Period
In the GCC organ preservation market, the kidney segment is significantly influenced by the rising incidence of kidney diseases such as end-stage renal disease (ESRD) and the growing demand for kidney transplants. The region's emphasis on kidney preservation is further highlighted by rising kidney-related health concerns, technological innovations, and backing from governmental bodies.
In April 2024, data from the International Registry in Organ Donation and Transplantation revealed that several GCC countries are increasingly relying on deceased individuals for organ donations. In 2023, Saudi Arabia led the way with 46.4% of its total kidney donations coming from deceased donors, followed closely by Qatar at 70.3% and the UAE at 51.6%. This rise in kidney donations highlights a pressing demand for sophisticated preservation systems to ensure the success of transplants.
Furthermore, the kidney preservation market in the GCC is driven by continuous healthcare advancements and technological integration, which are expected to enhance patient outcomes significantly. A notable example of this progress is the Saudi Center for Organ Transplantation's achievement in September 2023, when they successfully performed 20 organ transplants on 19 patients. This included two heart transplants, one lung, five livers, one pancreas, and 11 kidney transplants.
In addition, proactive regulatory bodies in the GCC, such as the Saudi Center for Organ Transplantation, have been instrumental in promoting kidney transplantation. A landmark moment was the establishment of the National Kidney Center, as mandated by Royal Decree No. 7/1561/M on 19/5/1404 AH, which has greatly enhanced kidney treatment and transplantation in Saudi Arabia.
With rising donations, technological advancements, and supportive regulations, the GCC's commitment to kidney preservation is unmistakable. Countries like Saudi Arabia, Qatar, and Kuwait are leading the charge, pouring investments into organ transplantation infrastructure to address the growing prevalence of kidney diseases.
UAE is Expected to Hold a Significant Market Share Over the Forecast Period
The UAE's organ preservation market is experiencing remarkable growth, primarily fueled by stringent government regulations advocating organ transplantation and a rising trend in organ donations.
The UAE government has launched initiatives like the Hayat Organ Donation Program, led by the Ministry of Health and Prevention, instrumental in promoting organ donation and transplantation. This program has played a pivotal role in boosting organ donations, evidenced by a 417% increase in organ donors per million population over the past five years. Over this period, the country has successfully conducted more than 958 organ transplants, with 153 of those in 2024.
Additionally, government initiatives to spread awareness about organ transplantation can drive the perfusion systems market by increasing public and healthcare provider knowledge. This leads to a higher number of organ donors and transplant procedures, thereby boosting the demand for products used in organ preservation and transportation.
For instance, in January 2024, at Arab Health 2024, held at the Dubai World Trade Centre in January to February, the UAE Health Authorities showcased advancements in the "Hayat" program, which focuses on the donation and transplantation of human organs and tissues. The Ministry of Health and Prevention (MoHAP), in collaboration with the Department of Health – Abu Dhabi (DoH) and the Dubai Health Authority (DHA), participated under the unified platform “Emirates Health.” Their joint efforts aimed to promote a culture of organ donation, both during life and posthumously, with the objectives of saving the lives of patients with organ failure, reducing the burden on families, and improving the quality of life for patients.
Thus, heightened awareness and improved donation rates will not only enhance patient outcomes but also stimulate growth in the organ preservation market, which is projected to reach significant valuations in the coming years. This synergy between awareness initiatives and market demand underscores the importance of government involvement in healthcare.
In addition, the UAE's healthcare sector is increasingly adopting advanced technologies, driving the organ preservation market. A testament to this is Dubai's King's College Hospital, which achieved a significant milestone in December 2023 by conducting one of the city's inaugural liver transplants. Such achievements underscore the nation's capability in managing intricate transplant procedures, amplifying the demand for sophisticated organ preservation techniques. With ongoing investments in cutting-edge medical technologies, the UAE's healthcare system is primed for complex transplantations, further accelerating the organ preservation market's expansion.
With strong government backing, supportive policies, and technological strides, the UAE's organ preservation market is on the brink of substantial growth. Programs like Hayat and recent legislative changes have significantly boosted organ donations, laying a solid foundation for the market's expansion. As the UAE fortifies its healthcare infrastructure and embraces pioneering medical technologies, the organ preservation market is poised for notable growth in the coming years.
GCC Organ Preservation Industry Overview
The GCC organ preservation market is semi-consolidated and dominated by global players, with only a limited number of regional participants. Market players, bolstered by government support, are ramping up organ preservation and transplant initiatives, fueling the market's expansion. Key players in this competitive landscape comprise international giants and notable local entities. These include Bridge to Life (Europe) Ltd., 21st Century Medicine Inc., Organ Recovery Systems, Inc., Organox Limited, and Paragonix Technologies, Inc., among others.
GCC Organ Preservation Market Leaders
-
Bridge to Life (Europe) Ltd.
-
Paragonix Technologies, Inc.
-
Organox Limited
-
Waters Medical Systems LLC
-
Transmedics Inc.
- *Disclaimer: Major Players sorted in no particular order
GCC Organ Preservation Market News
- June 2024: Bridge to Life Ltd unveiled new results from its Bridge to HOPE clinical trial, which employed the VitaSmart Machine Perfusion System. This trial evaluates the efficacy and safety of static cold storage (SCS), the prevailing standard for ex-vivo organ preservation. The study juxtaposes SCS with a combination of SCS and hypothermic oxygenated perfusion (HOPE), focusing on the transplantation of extended-criteria livers sourced from both brain death (DBD) and circulatory death (DCD) donors.
- January 2024: Dubai will host the 2024 Annual UAE Organ Donation and Transplantation Congress, as announced by the Ministry of Health and Prevention (MoHAP). This event is a testament to the government's commitment to promoting the significance of organ donation. By harnessing the UAE's state-of-the-art medical facilities, expert healthcare professionals, and innovative technology, the congress aims to enhance awareness and acceptance of organ donation. Furthermore, it highlights the UAE's aspiration to take a leading role in organ and tissue transfer and transplantation, both in the region and on the global stage.
GCC Organ Preservation Industry Segmentation
As per the scope of the report, organ preservation is the ability to maintain ex vivo organ viability and the capacity to restore normal organ function at restitution of physiological blood flow. The organ preservation market is segmented by technique, product type, organ type, and geography. By technique, the market is segmented into static cold storage (SCS) technique, hypothermic machine perfusion, and normothermic machine perfusion. By product type, the market is segmented into preservation solutions, transport systems, and others. By organ type, the market is segmented into kidneys, liver, lung, heart, and others. By geography, the market is segmented into Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, and Oman. The report also offers the market size and forecasts for six countries across the region. For each segment, the market sizing and forecasts have been done on the basis of revenue (USD).
| By Technique | Static Cold Storage (SCS) Technique |
| Hypothermic Machine Perfusion | |
| Normothermic Machine Perfusion | |
| By Product Type | Preservation Solutions |
| Transport Systems | |
| Others | |
| By Organ Type | Kidneys |
| Liver | |
| Lung | |
| Heart | |
| Others | |
| Geography | Saudi Arabia |
| United Arab Emirates | |
| Bahrain | |
| Kuwait | |
| Qatar | |
| Oman |
GCC Organ Preservation Market Research FAQs
How big is the GCC Organ Preservation Market?
The GCC Organ Preservation Market size is expected to reach USD 6.87 million in 2025 and grow at a CAGR of 5.51% to reach USD 8.99 million by 2030.
What is the current GCC Organ Preservation Market size?
In 2025, the GCC Organ Preservation Market size is expected to reach USD 6.87 million.
Who are the key players in GCC Organ Preservation Market?
Bridge to Life (Europe) Ltd., Paragonix Technologies, Inc., Organox Limited, Waters Medical Systems LLC and Transmedics Inc. are the major companies operating in the GCC Organ Preservation Market.
What years does this GCC Organ Preservation Market cover, and what was the market size in 2024?
In 2024, the GCC Organ Preservation Market size was estimated at USD 6.49 million. The report covers the GCC Organ Preservation Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the GCC Organ Preservation Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
GCC Organ Preservation Industry Report
Statistics for the 2025 GCC Organ Preservation market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. GCC Organ Preservation analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
